Ffcm LLC Sells 50,475 Shares of Colgate-Palmolive (CL)

Ffcm LLC reduced its position in Colgate-Palmolive (NYSE:CL) by 89.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 5,818 shares of the company’s stock after selling 50,475 shares during the quarter. Ffcm LLC’s holdings in Colgate-Palmolive were worth $391,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. CSat Investment Advisory L.P. purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $111,000. Bridgeworth LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $120,000. Price Capital Management Inc. purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $121,000. Fort L.P. purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $123,000. Finally, O Brien Wealth Partners LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $123,000. 75.22% of the stock is currently owned by institutional investors.

In related news, CFO Henning I. Jakobsen sold 1,015 shares of the business’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total value of $68,055.75. Following the sale, the chief financial officer now directly owns 36,193 shares in the company, valued at approximately $2,426,740.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Philip G. Shotts sold 462 shares of the business’s stock in a transaction dated Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $30,977.10. Following the completion of the sale, the vice president now owns 41,250 shares in the company, valued at $2,765,812.50. The disclosure for this sale can be found here. 1.02% of the stock is owned by insiders.

Several equities research analysts have commented on the stock. Argus restated a “buy” rating and set a $75.00 target price (up from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Atlantic Securities assumed coverage on shares of Colgate-Palmolive in a research report on Thursday, September 20th. They set a “neutral” rating and a $71.00 target price on the stock. ValuEngine upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Finally, Wells Fargo & Co restated a “hold” rating and set a $64.00 target price on shares of Colgate-Palmolive in a research report on Friday, July 27th. Four investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $68.06.

Colgate-Palmolive stock opened at $62.40 on Friday. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $77.91. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.77 and a current ratio of 1.11. The stock has a market capitalization of $53.65 billion, a P/E ratio of 21.74, a price-to-earnings-growth ratio of 3.04 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 26th. The company reported $0.72 EPS for the quarter, hitting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same period in the previous year, the firm earned $0.73 EPS. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. Analysts forecast that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Friday, October 19th were given a $0.42 dividend. The ex-dividend date of this dividend was Thursday, October 18th. This represents a $1.68 annualized dividend and a dividend yield of 2.69%. Colgate-Palmolive’s dividend payout ratio is presently 58.54%.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://transcriptdaily.com/2018/11/16/ffcm-llc-sells-50475-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: What is a Swap?

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply